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Prospective Comparison of the Minnesota Multiphasic Personality 
Inventory-2 (MMPI-2) and MMPI-2-Restructured Form (MMPI-2-RF) 
in Predicting Treatment Outcomes Among Patients with Chronic Low 
Back Pain
Anthony M. Tarescavage1 · Judith Scheman2 · Yossef S. Ben‑Porath3
Abstract
The purpose of the current study was to examine the relative utility of the most updated MMPI adult instrument, the Min-
nesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF), which was designed to address 
psychometric limitations of the MMPI-2. To this end, we compared mean scores and correlates of emotional distress 
treatment outcomes using the Depression Anxiety Stress Scales in a sample of 230 patients (73 males, 157 females) who 
had completed an inter-disciplinary chronic pain rehabilitation program. Structural equation modeling analyses indicated 
that higher scale scores from all the MMPI-2-RF substantive domains were meaningfully associated with worse emotional 
distress outcomes, whereas the MMPI-2 Clinical Scales generally did not have any meaningful associations. Similar 
results were found in additional analyses using a clinically significant change framework with more direct clinical 
implications. The results of this study provide preliminary support for the use of the MMPI-2-RF among patients with 
chronic low back pain.
Keywords MMPI-2-RF · Chronic pain · Back pain · Treatment outcome · Applied assessment
Introduction
Chronic low back pain has a considerable impact on society. 
The prevalence of the disorder is rising (Freburger et al., 
2009; Rubin, 2007), which is a prominent cause of disability 
(McNeil & Binette, 2001) and sick days (LaBar, 1992), and 
it has substantial economic influence (Guo, Tanaka, Halp-
erin, & Cameron, 1999; Katz, 2006). Moreover, it is associ-
ated with psychological problems, as the 12-month preva-
lence rates of mood and anxiety disorders in this population 
are 17.5 and 26.5% (Von Korff et al., 2005), respectively, 
which are nearly double the general population prevalence 
rates (Kessler et al., 2004). Chronic pain is also associated 
with the increased rates of illicit drug use, particularly opi-
oid abuse (Manchikanti et al., 2006).
According to the biopsychosocial perspective of pain 
(Gatchel, McGeary, McGeary, & Lippe, 2014; Gatchel, 
Peng, Peters, Fuchs, & Turk, 2007), biological, psychologi-
cal, and social factors interact to influence the experience of 
pain. Gatchel et al. (2007) provide an overview of how these 
factors affect the perception of illness, noting that pertinent 
psychological factors include mood problems, such as anxi-
ety and depression, as well as cognitions that may lead to 
pain catastrophizing. The American College of Physicians 
and the American Pain Society recommend interdisciplinary 
treatment with an assessment of these and other psychoso-
cial factors (Chou et al., 2007). They have been found to be 
stronger predictors of outcome than physical examinations, 
severity of pain, and duration of pain (Chou et al., 2007).
Psychological testing is one way to assess for these fac-
tors, with the Minnesota Multiphasic Personality Inven-
tory (MMPI) (Hathaway & McKinley, 1943) and MMPI-2 
(Butcher et al., 2001) historically having been the most 
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frequently used psychological tests among chronic pain 
patients (Piotrowski, 1998; Piotrowski & Lubin, 1990). 
However, use of these instruments began to decline in 
chronic pain settings in the mid-to-late-1990s. During this 
time, a series of articles debating the utility of the instrument 
were published in Pain Forum. Main and Spanswick (1995) 
began the debate with an article entitled “Personality Assess-
ment and the Minnesota Multiphasic Personality Inventory: 
50 years on: Do we still need our security blanket?” The 
authors criticized the test for its psychometric shortcomings, 
writing, “Its inherent structural weaknesses undermine its 
clinical validity, even when it does provide additional clini-
cal information” (p. 92). They called for prospective chronic 
pain outcome studies using advanced quantitative analyses 
such as structural equation modeling and measures “which 
reflect the world of pain rather than promulgate the sort of 
psychoarcheology represented by the MMPI and MMPI-2” 
(p. 95). Most of these concerns were echoed by other authors 
in the debate (Keefe, Lefebvre, & Beaupre, 1995; Turk & 
Fernandez, 1995). However, Bradley (1995) countered these 
claims by reviewing a series of research studies indicating 
that individuals can be reliably categorized into MMPI Scale 
score subgroups, which demonstrate concurrent associations 
with factors that may predict outcome (such as pain inten-
sity, medication use, disability, and work status). Overall, 
most of the authors in the series agreed that significant 
problems with the test’s Clinical Scales (which were nearly 
identical to the MMPI’s Clinical Scales) limited the test’s 
utility in this setting.
Several years after the debate, the MMPI-2-Restructured 
Form (MMPI-2-RF; Ben-Porath & Tellegen, 2008/2011), 
was released as an updated version of the MMPI-2. The 
MMPI-2-RF is a 338-item broadband measure of psy-
chopathology with 51 scales. The nine Validity Scales of 
the test are designed to assess for problematic test-taking 
approaches, which include random and acquiescent respond-
ing, as well as over- and underreporting of psychological 
problems. The test’s substantive scales measure psychologi-
cal constructs and are anchored by the nine Restructured 
Clinical (RC) Scales. The primary goal of the RC Scales 
project was to address the psychometric limitations of the 
Clinical Scales by substantially reducing the scale overlap 
and heterogeneity that complicated their interpretation and 
use in research, while still measuring the major distinctive 
core constructs assessed by each scale. The constructs meas-
ured by the scales were also more clearly tied to modern 
psychopathology models and constructs (Sellbom, Ben-
Porath, & Bagby, 2008). These revisions address some of 
the primary concerns with the Clinical Scales advanced by 
authors in the debate.
The MMPI-2-RF test authors used similar modern scale 
development strategies for two substantive scale sets that 
complement the RC Scales: (1) the three Higher-Order 
Scales that measure internalizing dysfunction, thought dys-
function, and externalizing dysfunction, broadly defined, 
and; (2) the 23 Specific Problems Scales that measure RC 
Scale subdomains or other, more narrowly focused con-
structs that are related to, but distinct from those measured 
by the RC Scales. Revised and improved versions of the 
MMPI-2 PSY-5 Scales, which measure broad domains of 
abnormal personality, are also included on the test. Over-
all, the MMPI-2-RF measures five substantive domains of 
personality and psychopathology: (1) Emotional Dysfunc-
tion; (2) Thought Dysfunction; (3) Behavioral/Externalizing 
Dysfunction; (4) Somatic/Cognitive Problems; and (5) Inter-
personal Functioning (see Table 1 for scale descriptions).
McCord and Drerup (2011) demonstrated the improved 
interpretive utility of the RC Scales in comparison to the 
Clinical Scales in a chronic pain sample. These authors cat-
egorized 316 chronic pain patients into depressed and non-
depressed diagnostic groups. The depression group included 
individuals diagnosed with major depression, dysthymia, 
and adjustment disorder, whereas the nondepressed group 
was not diagnosed with any form of mood disturbance. They 
compared mean scores on the Clinical and RC Scales across 
the two groups. In the nondepressed group, mean Clinical 
Scale elevations (i.e., scores ≥ 65T) were found on scales 
1 (Hypochondriasis), 2 (Depression), 3 (Hysteria), and 8 
(Schizophrenia), whereas only RC1 (Somatic Complaints) 
produced a mean RC Scale elevation. In the depressed 
group, mean clinical elevations were observed for the fol-
lowing Clinical Scales: 1 (Hypochondriasis), 2 (Depression), 
3 (Hysteria), 4 (Psychopathic Deviate), 6 (Paranoia), 7 (Psy-
chastenia), and 8 (Schizophrenia). The pattern of elevations 
was consistent with the neurotic-triad cluster and code type 
typically found in Clinical Scale research in this setting, with 
prominent elevations on scales 1, 2, and 3. In stark contrast 
to the Clinical Scale findings, mean RC scale elevations were 
observed in the depressed group for only RCd (Demoraliza-
tion), RC1 (Somatic Complaints), and RC2 (Low Positive 
Emotions), demonstrating substantially improved discrimi-
nant validity. McCord and Drerup (2011) summarize the 
implications of the findings from the depressed group:
“The clinician relying on the Clinical Scales would see 
clinical-range elevations on all scales except Scale 9, with 
extreme elevations on Scales 1, 2, and 3 and troubling eleva-
tions on 7 and 8 as well. In contrast, the RC Scales indicate 
three things: (a) a significant level of demoralization; (b) 
significant somatic complaints; and (c) depression. The latter 
set of data is far more consistent with the clinical diagnoses 
in the patient charts” (p. 145).
Current Study
Despite the substantial psychometric and interpretive 
improvements compared to the Clinical Scales, no study has 
68 
Table 1  Minnesota Multiphasic Personality Inventory-2-Restructured Form Scales
Validity Scales
 Inconsistent responding
  VRIN-r Variable response inconsistency-random responding
  TRIN-r True response inconsistency-fixed responding
 Overreporting
F-r Infrequent responses—responses infrequent in the general population
Fp-r Infrequent psychopathology responses—responses infrequent in psychiatric populations
FS Infrequent somatic responses—somatic complaints infrequent in medical patient populations
FBS-r Symptom validity—somatic and cognitive complaints associated at high levels with overreporting
RBS Response bias scale—exaggerated memory complaints
 Underreporting
L-r Uncommon virtues—rarely claimed moral attributes or activities
K-r Adjustment validity—avowals of good psychological adjustment associated at high levels with underre-
porting
Higher-Order (H-O) Scales
 EID Emotional/internalizing dysfunction—problems associated with mood and affect
 THD Thought dysfunction—problems associated with disordered thinking
 BXD Behavioral/externalizing dysfunction—problems associated with under-controlled behavior
Restructured Clinical (RC) Scales
 RCd Demoralization—general unhappiness and dissatisfaction
 RC1 Somatic complaints—diffuse physical health complaints
 RC2 Low positive emotions—lack of positive emotional responsiveness
 RC3 Cynicism—non-self-referential beliefs expressing distrust and a generally low opinion of others
 RC4 Antisocial behavior—rule breaking and irresponsible behavior
 RC6 Ideas of persecution—self-referential beliefs that others pose a threat
 RC7 Dysfunctional negative emotions—maladaptive anxiety, anger, and irritability
 RC8 Aberrant experiences—unusual perceptions or thoughts
 RC9 Hypomanic activation—overactivation, aggression, impulsivity, and grandiosity
Specific Problem (SP) Scales
 Somatic/Cognitive Scales
  MLS Malaise—overall sense of physical debilitation, poor health
  GIC Gastrointestinal complaints—nausea, recurring upset stomach, and poor appetite
  HPC Head pain complaints—head and neck pain
  NUC Neurological complaints—dizziness, weakness, paralysis, loss of balance, etc
  COG Cognitive complaints—memory problems, difficulties concentrating
 Internalizing Scales
  SUI Suicidal/death ideation—direct reports of suicidal ideation and recent suicide attempts
  HLP Helplessness/hopelessness—belief that goals cannot be reached or problems solved
  SFD Self-doubt—lack of confidence, feelings of uselessness
  NFC Inefficacy—belief that one is indecisive and inefficacious
  STW Stress/worry—preoccupation with disappointments, difficulty with time pressure
  AXY Anxiety—pervasive anxiety, frights, frequent nightmares
  ANP Anger proneness—becoming easily angered, impatient with others
  BRF Behavior-restricting fears—fears that significantly inhibit normal activities
  MSF Multiple specific fears—fears of blood, fire, thunder, etc
 Externalizing Scales
  JCP Juvenile conduct problems—difficulties at school and at home, stealing
  SUB Substance abuse—current and past misuse of alcohol and drugs
  AGG Aggression—physically aggressive, violent behavior
  ACT Activation—heightened excitation and energy level
investigated use of the RC Scales to predict outcomes among 
chronic pain patients undergoing conventional conservative 
treatments. The purpose of the current study was to investi-
gate the ability of the MMPI-2-RF to predict self-reported 
emotional distress outcomes among patients with chronic 
low back pain completing short-term interdisciplinary reha-
bilitation treatment. Because this is the first comprehensive 
investigation of the revised inventory, rather than test-spe-
cific hypotheses, in the context of discovery (Reichenbach, 
1938), we investigated the association between all MMPI-
2-RF scale scores with emotional distress outcomes (as
measured by the Depression Anxiety Stress Scales) (Lovi-
bond & Lovibond, 1995) after controlling for age and gen-
der, as well as pain intensity and duration of pain. In line
with suggestions by Main and Spanswick (1995), we exam-
ined these associations using structural equation modeling.
Finally, we compared the scores of interpretive utility and
the predictive capacity of the MMPI-2-RF scales and the
MMPI-2 Clinical Scales, and we expected that the MMPI-
2-RF scales would demonstrate substantially greater inter-
pretive utility and larger effect sizes in predicting outcome
given its structural and theoretical improvements.
Methods
Participants
Participants were drawn from an archival sample of 278 non-
consecutive chronic pain patients (93 males, 185 females) 
who presented with lower back pain to a 3–4 week interdisci-
plinary pain treatment program in Northeast Ohio and were 
administered the MMPI-2 as well as the Depression Anxi-
ety Stress Scales (DASS) at intake. Overall, 249 (89.6%) of 
these individuals were eligible for inclusion because they 
completed the program and were administered the DASS 
at discharge. Completers participated in the program for an 
average of 20.6 days (SD = 6.8).
MMPI-2 items were used to calculate MMPI-2-RF scale 
scores, which is possible because all 338 MMPI-2-RF 
items are included in the MMPI-2 booklet. Past research 
has demonstrated the relative comparability of MMPI-2-RF 
scale scores generated from both booklets (Tellegen & Ben-
Porath, 2008/2011; Van der Heijden, Egger, & Derksen, 
2010). An additional 19 participants were excluded from the 
analyses because they produced invalid MMPI-2-RF profiles 
according to the test authors’ published guidelines, which 
included cannot say, CNS ≥ Raw score 18; variable response 
inconsistency, VRIN-r ≥ 80; true response inconsistency, 
TRIN-r ≥ 80; infrequent responding, F-r = 120; and infre-
quent psychopathology responses, Fp-r ≥ 100 (Ben-Porath 
& Tellegen, 2008/2011).
The final sample included 230 patients (73 males, 157 
females) after exclusions.1 The majority of the sample was 
married (62.6%) and other martial statuses included never 
Table 1  (continued)
 Interpersonal Scales
  FML Family problems—conflictual family relationships
  IPP Interpersonal passivity—being unassertive and submissive
  SAV Social avoidance—avoiding or not enjoying social events
  SHY Shyness—bashful, prone to feel inhibited and anxious around others
  DSF Disaffiliativeness—disliking people and being around them
Interest Scales
 AES Aesthetic-literary interests—literature, music, the theater
 MEC Mechanical–physical interests—fixing and building things, the outdoors, sports
Personality Psychopathology Five (PSY-5) Scales
 AGGR-r Aggressiveness-revised—instrumental, goal directed aggression
 PSYC-r Psychoticism-revised—disconnection from reality
 DISC-r Disconstraint-revised—under-controlled behavior
 NEGE-r Negative emotionality/neuroticism-revised—anxiety, insecurity, worry, and fear
 INTR-r Introversion/low positive emotionality-revised—social disengagement and anhedonia
From MMPI-2-RF Manual for Administration, Scoring, and Interpretation by Yossef S. BenPorath and Auke Tellegen. Copyright© 2008, 2011 
by the Regents of the University of Minnesota. Reproduced by permission of the University of Minnesota Press. All rights reserved. “Minnesota 
Multiphasic Personality Inventory-2-RF®” and “MMPI-2-RF®” are trademarks owned by the Regents of the University of Minnesota
1 There were a total of 14 additional participants (6% of sample) who 
would have been excluded from the study if we removed individuals 
with elevated scores (≥ 100T) on Fs, FBS-r, or RBS. According to 
Ben-Porath and Tellegen (2008/2011), elevated scores on these three 
validity scales suggest scores on the Somatic/Cognitive scales may 
be invalid. We ran the study analyses after excluding these 14 indi-
viduals, and the interpretation of the findings did not meaningfully 
change.
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married (19.6%), divorced (10.0%), widowed (3.0%), and 
separated (1.3%). The average age was 46.5 (SD = 14.5) 
,and the average years of education was 14.3 (SD = 3.1). 
No significant differences were observed on most demo-
graphic variables between the excluded individuals and 
the final sample (p’s > .23). However, excluded individu-
als were more likely to have a marital status of separated, 
χ2(5) = 11.455, p = .043, Std. residual = 2.6. In the final 
sample, the most common DSM-IV-TR (American Psychi-
atric Association, 2000) diagnoses included major depres-
sive disorder (48.8%), a substance use disorder (36.3%), 
an anxiety disorder (18.2%), a bipolar disorder (4.9%), 
post-traumatic stress disorder (2.6%), or a somatization 
disorder (0.9%)(categories are not mutually exclusive). To 
some extent, these rates may underestimate comorbid psy-
chopathology because billing was not based the presence 
of a mental disorder. Common comorbid medical condi-
tions included joint pain (44.8%), neck pain (38.7%), foot 
pain (29.1%), fibromyalgia (25.8%), migraine (19.7%), 
arthritis (18.3%), neuropathic pain (17.8%), abdominal 
pain (10.4%), myofascial pain (5.7%), chronic regional 
pain syndrome (5.2%), chronic fatigue syndrome (3.9%), 
tension headache (3.5%), dizziness (3.1%), and diabetes 
(3.1%). In terms of medications at intake, 67.6% were pre-
scribed an antidepressant and 61.9% were prescribed pain 
medications.
Measures
MMPI-2-RF
The MMPI-2-RF is described in detail in the Introduction. 
Psychometric properties of scores from the instrument 
are reported by Tellegen and Ben-Porath (2008/2011). 
Descriptive statistics and reliability estimates are provided 
for the Validity Scales in Table 2, the Restructured Clini-
cal Scales in Table 3, and the remaining substantive scales 
in Table 3.
MMPI-2
The MMPI-2 Clinical Scales were examined in this study 
because the vast majority of MMPI chronic pain research 
focuses on these scales (Tarescavage, 2015). The MMPI-2 
Manual (Butcher et al., 2001) provides detailed information 
on the psychometrics of Clinical Scale scores in a variety of 
different samples. Of note, the Masculinity–Feminity and 
Introversion Clinical Scales were not investigated because 
they do not measure constructs relevant to psychopathology. 
Reliability estimates of MMPI-2 Clinical Scale scores in the 
current sample are provided in Table 3.
Depression, Anxiety, Stress Scales
The Depression, Anxiety, Stress Scales (DASS) (Lovibond 
& Lovibond, 1996) is a 42-item self-report measure of mood 
problems. It has three scales measuring depression, anxiety, 
and generalized distress. Scores from the test have demon-
strated adequate internal consistency reliability in a variety 
of settings (Lovibond & Lovibond, 1996) and have docu-
mented sensitivity to change (Page, Hooke, & Morrison, 
2007).
Pain Variables
Patients rated the severity of their pain at intake on 11-point 
scales (0–10). The average pain intensity was 6.7 (SD = 2.0). 
They also reported the duration of their pain, which ranged 
from 1 to 63  years. The average duration of pain was 
11.6 years (SD = 9.9).
Procedure
Upon admission to the Chronic Pain Rehabilitation Pro-
gram (CPRP), all patients were given the MMPI-2 as part 
of a battery of tests including self-reported measures, and 
extensive patient and collateral interviews. The MMPI-2 
was used, in part, to render psychological diagnoses, but 
largely to guide treatment. Participants were not excluded 
from treatment based on MMPI-2 scores. Evaluation dates 
ranged from 1999 to 2008. The CPRP is a comprehensive, 
intensive, interdisciplinary program that includes physical 
therapy, occupational therapy, group and individual psycho-
logical therapy, and medication management, including the 
weaning of all addicting substances including opioids and 
Table 2  MMPI-2-RF Validity Scale Scores (N = 230)
MMPI-2-RF Minnesota Multiphasic Personality Inventory-2-Restruc-
tured Form, RC restructured clinical, M mean, SD standard deviation, 
α Cronbach’s alpha
MMPI-2-RF scale name (abbreviation) α M SD
Inconsistent responding
 Variable response inconsistency (VRIN-r) .17 51.6 9.7
 True response inconsistency (TRIN-r) .12 57.4 6.4
Overreporting Scales
 Infrequent responses (F-r) .70 69.2 15.5
 Infrequent psychopathology responses (Fp-r) .37 52.6 10.8
 Infrequent somatic responses (Fs) .58 64.8 18.2
 Symptom validity (FBS-r) .67 71.2 13.2
 Response bias (RBS) .68 66.4 15.8
Underreporting Scales
 Uncommon virtues (L-r) .44 53.4 9.3
 Adjustment validity (K-r) .65 46.7 9.4
benzodiazepines as well as sedative hypnotics. Education 
about addiction and chemical dependency was offered as 
needed. The average length of stay is 3½ weeks and the 
treatment day extends from 7:30 am–5 pm, 5 days a week. 
Use of the sample was approved by an institutional review 
board.
Analysis Plan
MMPI-2 and MMPI-2-RF Mean Score Comparisons
We first examined mean score differences between the 
MMPI-2 Clinical Scales and MMPI-2-RF RC Scales in 
the sample. We compared the values using Cohen’s d, with 
values of .30, .50, and .80 representing small, medium, 
and large differences, respectively (Cohen, 1992). This 
analysis was intended to build on research by McCord and 
Drerup (2011) who found that the structural problems of 
the MMPI-2 Clinical Scales limited their interpretive util-
ity relative to the MMPI-2-RF RC Scales. These authors 
categorized a sample of chronic pain patients into depressed 
and nondepressed diagnostic groups. In the depressed group 
in their study, mean clinical elevations were observed for the 
following Clinical Scales: 1 (Hypochondriasis), 2 (Depres-
sion), 3 (Hysteria), 4 (Psychopathic Deviate), 6 (Paranoia), 
7 (Psychastenia), and 8 (Schizophrenia). In stark contrast to 
the Clinical Scale findings, mean RC scale elevations were 
observed in the depressed group for only RCd (demorali-
zation), RC1 (somatic complaints), and RC2 (low positive 
emotions), demonstrating substantially improved discrimi-
nant validity and interpretive utility.
MMPI-2 and MMPI-2 RF Associations with Outcome
Associations between the MMPI-2 Clinical Scales and 
MMPI-2-RF substantive scales, on the one hand, and treat-
ment outcomes, on the other, were examined next in a struc-
tural equation modeling framework. All the analyses were 
completed in Mplus. Version 6.11 (Muthén & Muthén, 2010) 
using the Maximum Likelihood (ML) estimator. Model fit 
was evaluated using the χ2 test, the Comparative Fit Index 
(CFI) (Bentler, 1990), the Tucker Lewis Index (TLI) (Bentler 
& Bonett, 1980), and the Root Mean Square of Approxi-
mation (RMSEA) (Steiger, 1998). Nonsignificant χ2 tests 
(p > .05), CFI and TLI values greater than .90, and RMSEA 
values less than .08 are indicative of adequate fit (Bentler, 
1990; Browne, Cudeck, Bollen, & Long, 1993; Vandenberg 
& Lance, 2000; Yu, 2002). However, because the  χ2 test is 
overpowered in larger samples like the current one, statisti-
cally significant findings do not necessarily indicate poor fit.
We first identified a measurement model for the outcome 
variable, with scales from the DASS being used to model 
latent emotional distress factors at intake and discharge. We 
specified the intake factor as a predictor of the discharge fac-
tor to control for baseline emotional functioning (see Fig. 1 
for final parameter estimates), a method recommended by 
Little (2013). The indicators were approximately normally 
distributed, supporting use of maximum likelihood estima-
tion. The resulting model fit adequately. Specifically, the 
χ2 test was nonsignificant (χ2[5] = 8.23, p = .14), and the 
other fit indices were also adequate (CFI = .99; TLI = .99; 
RMSEA = .05, 95% CI = .00 to .087). As reported later, we 
next specified age, gender, pain intensity, and duration of 
Table 3  MMPI-2-RF RC Scales and MMPI-2 Clinical Scales descriptives and correlations with latent emotional distress outcome controlling for 
intake emotional distress, gender, age, pain intensity, and pain duration
Consistent with interpretive guidelines, Clinical Scales are K-corrected (Graham, 2012)
Italicized findings attained a statistically significant and clinically meaningful effect size (r ≥ .20)
MMPI-2-RF Minnesota Multiphasic Personality Inventory-2-Restructured Form, RC restructured clinical, M mean, SD standard deviation. 
routcome correlation with outcome variable, d Cohen’s d comparing mean RC versus CS scores, α Cronbach’s alpha
a RC3 measures one component of CS3, naivete, which is reversed to measure cynicism. Therefore, the RC3/CS3 comparisons reflect not only 
differences in psychometric properties but also in direction of keying
*p < .05; **p < .01; ***p < .001
MMPI-2-RF Scale name (abbreviation) α M SD routcome MMPI-2 Scale name (abbreviation) α M SD routcome d
Restructured Clinical Scales Clinical Scales
Demoralization (RCd) .89 62.4 11.0 .29*** – – – – –
Somatic complaints (RC1) .80 71.1 11.4 .13 Hypochondriasis (CS1) .80 76.5 10.3 − .05 .50
Low positive emotions (RC2) .70 62.3 11.5 .13 Depression (CS2) .41 76.6 13.3 .04 1.15
Cynicism (RC3) .83 48.2 10.4 .34*** Hysteria (CS3) .65 78.7 13.8 − .10 2.52a
Antisocial behavior (RC4) .73 51.5 10.0 .21** Psychopathic deviate (CS4) .64 62.8 11.9 .02 1.03
Ideas of persecution (RC6) .66 53.5 11.2 .26*** Paranoia (CS6) .43 60.8 11.8 .13 .63
Dysfunctional negative emotions (RC7) .85 54.1 11.6 .38*** Psychasthenia (CS7) .88 67.9 12.0 .15 1.17
Aberrant experiences (RC8) .67 53.8 10.2 .31*** Schizophrenia (CS8) .88 67.4 12.0 .20* 1.23
Hypomanic activation (RC9) .77 46.0 9.1 .30*** Mania (CS9) .49 52.0 9.3 .04 .65
pain as predictors of discharge emotional distress to control 
for these variables, a method also recommended by Little 
(2013). To identify associations between the MMPI-2-RF 
scales and future outcome, we correlated the test’s scales 
with the outcome variable at discharge. Traditional MMPI 
guidelines indicate that a correlation of .20 or greater is clin-
ically meaningful (Graham, Ben-Porath, & McNulty, 1999). 
Consistent with this guideline, we only interpreted statisti-
cally significant correlations (p < .05) yielding a magnitude 
of .20 or greater.
MMPI-2 and MMPI-2 RF Associations with Recovery
Finally, we examined associations between MMPI-2 and 
MMPI-2-RF scores and emotional distress outcome in the 
context of the clinically significant change model of out-
come measure progress developed by Jacobson and Truax 
(Jacobson & Truax, 1991). According to this model and 
in the context of this study, clinically significant recovery 
occurs when a distressed individual achieves a statistically 
significant and reliable change (i.e., 1.96 multiplied by the 
outcome measure’s standard error of difference) that is more 
characteristic of the general (nondistressed) population than 
the patient (distressed) population. For the purposes of the 
current study, individuals were deemed to have recovered if 
their DASS total score decreased/improved by 9.03 points 
(Reliable Change Index) to a score below 30.38 (midpoint 
between nondistressed and distressed population).
The just mentioned values were derived from DASS 
general population normative data provided by Crawford 
and Henry (Crawford & Henry, 2003) as well as the intake 
DASS scores in the current study using formula provided 
by Jacobson and Truax (1991). Specifically, for the Reli-
able Change Index, the general population normative data 
indicated a standard error of measurement of 3.26. Apply-
ing the following formula (Jacobson & Truax, 1991) 
yielded a value of 9.03 for the Reliable Change Index: 
1.96 × sqrt(2 × 3.262). For the midpoint between the non-
distressed versus distressed samples, we utilized means and 
standard deviations from the general population norma-
tive sample of DASS scores (M = 18.38, SD = 18.82) and 
from the study sample of intake DASS Scores (M = 48.41, 
SD = 28.28). The following formula (Jacobson & Truax, 
1991) yielded a value of 30.38 for the midpoint of the non-
distressed population versus distressed population: {[(28.2
8 × 18.38) + (18.82 × 48.41)]/(18.82 + 28.28)}.
DASS Total Scores were available at both the intake 
and discharge time points for 181 members of the current 
sample. Overall, 91 of these individuals (50.3%) met the 
criterion for recovered, such that their DASS Total Score 
decreased by more than 9.03 points (Reliable Change 
Index) to a value less than 30.38 (nondistressed vs. dis-
tressed population midpoint). Of the 90 remaining indi-
viduals, 10 individuals (5.5%) had a change that was less 
than the Reliable Change Index, 6 individuals (3.1%) had 
a reliable change in the direction of deterioration, and 17 
individuals (8.9%) had a reliable change in the direction 
of improvement but ultimately did not have a score below 
the nondistressed/distressed population midpoint of 30.38. 
These 33 individuals (18.2%) were therefore considered to 
have not recovered. The remaining 57 individuals (29.8%) 
had DASS intake and discharge scores that were both in 
the nondistressed range; therefore, they neither met crite-
ria for recovered nor nonrecovered. We compared mean 
Fig. 1  Emotional distress 
measurement model. All param-
eter estimates are statistically 
significant (p < .013). Manifest 
variables are scales from the 
depression anxiety stress scales. 
Residuals are in parentheses
Intake 
Emotional Distress
Discharge 
Emotional Distress
Depression Anxiety Stress Depression Anxiety Stress
.83
(.31)
.77
(.41)
.87
(.24)
.75
(.43)
.75
(.44)
.90
(.19)
.24
.39
.44
.30
MMPI-2 and MMPI-2-RF T-scores across the recovered 
(n = 91) and nonrecovered (n = 33) groups using t-tests 
and examined effect size using Cohen’s d. Consistent 
with traditional MMPI guidelines (Graham, Ben-Porath, & 
McNulty, 1999), we interpreted comparisons that yielded a 
statistically significant (p < .05) and clinically meaningful 
effect size (d ≥ .40, which is equivalent to r ≥ .20).
Results
MMPI‑2 and MMPI‑2‑RF Mean Score Comparisons
We present in Table  3 MMPI-2-RF RC Scale T-score 
means and standard deviations for this sample alongside 
MMPI-2 Clinical Scale T-score means and standard devia-
tions. The sample produced clinically significant mean ele-
vations (i.e., a score ≥ 65T) on only RC1 (Somatic Com-
plaints). The sample scored at or above 60T (one standard 
deviation above the general population mean) on RCd 
(Demoralization) and RC2 (Low Positive Emotions). In 
contrast, the sample produced clinically significant mean 
elevations on most of the MMPI-2 Clinical Scales, includ-
ing CS1 (Hypochondriasis), CS2 (Depression), CS3 (Hys-
teria), CS7 (Psychasthenia), and CS8 (Schizophrenia). The 
CS4 (Psychopathic Deviate) and CS6 (Paranoia) scales 
approached the threshold of a clinical elevation (both 
T-score were greater than 60). Only CS9 (Mania) was
within one standard deviation of the general population
mean (i.e., a T-score less than 60T). In general, MMPI-2
Clinical Scale T-scores were substantially higher than RC
Scale T-scores, with Cohen’s d values ranging from .50
(RC1/CS1) to 2.52 (RC3/CS3). Of note, RC3 measures one
component of CS3, naivete, which is reversed to measure
cynicism. For the interested reader, descriptive statistics
for the remaining MMPI-2-RF scales examined in this
study are presented in Table 2.
Effects of Age, Gender, Pain Intensity, and Duration 
of Pain on Outcomes
As detailed in the analysis plan, we used age, gender, pain 
intensity, and duration of pain as predictors of emotional 
distress outcomes in order to control for these variables. In 
the emotional distress model, age was a significant predic-
tor of outcome (Standardized coefficient = − .24, p = .004), 
but the remaining predictors were nonsignificant, includ-
ing gender (Standardized coefficient = − .05, p = .56), pain 
intensity (Standardized coefficient = − .13, p = .11), and 
duration of pain (Standardized coefficient = .04, p = .61).
MMPI‑2 and MMPI‑2 RF Associations with Outcome
We present in Table 3 correlations between the MMPI-2-RF 
RC scales and MMPI-2 Clinical Scales and emotional dis-
tress treatment outcomes after controlling for baseline func-
tioning in these areas, as well as age, gender, pain intensity, 
and pain duration. Most of the RC Scales were significantly, 
meaningfully associated with the criterion, with the follow-
ing scales yielding correlates greater than .20: RCd (Demor-
alizatoin), RC3 (Cynicism), RC4 (Antisocial Behavior), RC6 
(Persecutory Ideation), RC7 (Dysfunctional Negative Emo-
tions), RC8 (Aberrant Experiences), and RC9 (Hypomanic 
Activation). In contrast, only Clinical Scale 8 (Schizophre-
nia) was statistically and meaningfully associated with out-
come. Regarding the rest of the MMPI-2-RF substantive 
scales (see Table 4), all five substantive domains were rep-
resented as predictors of poor emotional distress outcomes, 
including emotional dysfunction (EID, HLP, NFC, STW, 
AXY, BRF, and NEGE-r), behavioral dysfunction (BXD, 
AGG, ACT, and DISC-r), thought dysfunction (THD and 
PSYC-r), interpersonal dysfunction (SHY and DSF), and 
somatic/cognitive dysfunction (MLS and COG).
MMPI‑2 and MMPI‑2 RF Associations with Recovery
Finally, we present in Table 5 mean score differences for the 
MMPI-2-RF RC Scales and MMPI-2 Clinical Scales across 
groups of individuals who either recovered following treat-
ment according to the DASS (n = 91) or those who did not 
recover according to this measure (n = 33). Most of the RC 
Scales were significantly and meaningfully different across 
the groups, with the following scales yielding Cohen’s d 
effect sizes greater than .40 (indicating higher-pretreatment 
scores in the nonrecovered group): RCd (Demoralizatoin), 
RC3 (Cynicism), RC4 (Antisocial Behavior), RC6 (Per-
secutory Ideation), RC7 (Dysfunctional Negative Emo-
tions), RC8 (Aberrant Experiences), and RC9 (Hypomanic 
Activation). In contrast, only Clinical Scale 9 (Mania) was 
statistically and meaningfully higher in the nonrecovered 
group of the two groups. Regarding the rest of the MMPI-
2-RF substantive scales (see Table 5), most of the substan-
tive domains were significantly and meaningfully higher in
the nonrecovered group, including behavioral dysfunction
(JCP, SUB, AGG, DISC-r), thought dysfunction (PSYC-
r), interpersonal dysfunction (DSF), and somatic/cognitive
dysfunction (COG). Overall and in general terms, mean
T-scores in the nonrecovered group approximated a clinical
elevation (65T) on scales measuring emotional dysfunction
and somatic/cognitive complaints, whereas they typically
approximated a score of 55T for scales measuring behavioral
dysfunction in this same group. Thought dysfunction scores
in the nonrecovered group approximated a T-score of 60.
Discussion
The purpose of this study was to examine the relative util-
ity of the MMPI-2-RF substantive scales compared to the 
MMPI-2 Clinical Scales in the prediction of emotional dis-
tress outcomes among patients with chronic low back pain 
undergoing intensive outpatient treatment. Descriptive 
analyses of MMPI-2-RF scores indicated that the current 
sample reported relatively high levels of somatic prob-
lems, as well as mood disorder-related symptomatology. 
However, in comparisons of the RC and MMPI-2 Clini-
cal Scales, scores on the latter suggested substantially 
more severity and variability in psychopathology. Finally, 
scales from all domains from the MMPI-2-RF demon-
strated associations with psychological distress outcome, 
whereas MMPI-2 Clinical Scale scores generally did not 
demonstrate meaningful associations. These results were 
consistent with clinically relevant comparisons across 
groups of individuals who at discharge either recovered 
or did not recover from their intake level of psychological 
Table 4  MMPI-2-RF higher-
order, specific problems, and 
personality psychopathology-5 
scale descriptives and 
correlations with latent 
emotional distress outcome 
controlling for intake emotional 
distress, gender, age, pain 
intensity, and pain duration
*p < .05; **p < .01; ***p < .001
Italicized findings attained a statistically significant and clinically meaningful effect size (r ≥ .20)
MMPI-2-RF Minnesota Multiphasic Personality Inventory-2-Restructured Form, RC restructured clinical, 
M mean, SD standard deviation, routcome correlation with outcome variable, d Cohen’s d comparing mean 
RC versus CS scores, α Cronbach’s alpha
MMPI-2-RF Scale name (abbreviation) α M SD routcome
Higher-Order Scales
 Emotional/internalizing dysfunction (EID) .90 62.2 11.6 .30***
 Thought dysfunction (THD) .64 53.0 9.9 .25***
 Behavioral/externalizing dysfunction (BXD) .77 48.6 9.8 .27***
Specific Problems Scales
 Malaise (MLS) .51 76.4 7.9 .21**
 Gastrointestinal complaints (GIC) .71 64.8 16.6 − .07
 Head pain complaints (HPC) .74 64.5 10.3 .10
 Neurological complaints (NUC) .66 69.9 13.2 .15
 Cognitive complaints (COG) .77 63.2 14.1 .39***
 Suicidal/death ideation (SUI) .67 54.8 16.0 .04
 Helplessness/hopelessness (HLP) .60 52.7 12.4 .31***
 Self-doubt (SFD) .75 58.7 12.0 .05
 Inefficacy (NFC) .76 53.9 11.6 .29***
 Stress/worry (STW) .60 56.7 11.3 .30***
 Anxiety (AXY) .62 57.7 14.8 .26**
 Anger proneness (ANP) .76 53.5 12.0 .20*
 Behavior-restricting fears (BRF) .52 53.9 12.0 .25***
 Multiple specific fears (MSF) .70 50.8 9.4 .09
 Juvenile conduct problems (JCP) .66 50.3 10.9 .19*
 Substance abuse (SUB) .63 50.3 10.1 .15
 Aggression (AGG) .61 48.6 9.4 .22**
 Activation (ACT) .59 47.9 9.9 .26***
 Family problems (FML) .68 53.0 11.1 .17*
 Interpersonal passivity (IPP) .70 52.2 10.7 .01
 Social avoidance (SAV) .80 53.0 11.0 .16*
 Shyness (SHY) .77 51.2 10.8 .26***
 Disaffiliativeness (DSF) .60 52.9 12.7 .29***
Personality-Psychopathology-5 Scales
 Aggressiveness-revised (AGGR-r) .76 47.3 9.6 .03
 Psychoticism-revised (PSYC-r) .62 52.9 9.8 .31***
 Disconstraint-revised (DISC-r) .75 48.2 9.8 .25**
 Negative emotionality/neuroticism-revised (NEGE-r) .81 57.9 12.3 .36***
 Introversion/low positive emotionality-revised (INTR-r) .79 57.3 12.2 .05
Table 5  Mean comparisons 
between emotional distress 
recovered and not recovered 
groups
Scale name (abbreviation) Recovered 
(n = 91)
Not 
recovered 
(n = 33)
Statistical comparisons
M SD M SD t Sig. d
MMPI-2-RF Higher-Order Scales
 Emotional/internalizing dysfunction (EID) 64.1 11.1 67.8 11.0 1.648 .102 .34
 Thought dysfunction (THD) 53.6 10.2 57.1 9.4 1.721 .088 .36
 Behavioral/externalizing dysfunction (BXD) 46.5 8.1 56.7 12.0 5.424 < .001 1.02
MMPI-2-RF restructured Clinical Scales
 Demoralization (RCd) 64.2 10.1 68.8 9.3 2.269 .025 .47
 Somatic complaints (RC1) 72.5 11.1 71.7 11.5 − 0.342 .733 − .07
 Low positive emotions (RC2) 63.0 11.0 63.9 13.4 0.386 .701 .07
 Cynicism (RC3) 48.0 9.4 56.5 14.0 3.871 < .001 .73
 Antisocial behavior (RC4) 49.6 9.3 57.5 11.5 3.914 < .001 .76
 Ideas of persecution (RC6) 53.8 11.7 59.9 11.6 2.596 .011 .53
 Dysfunctional negative emotions (RC7) 55.6 10.6 61.3 12.0 2.533 .013 .50
 Aberrant experiences (RC8) 54.3 10.0 59.0 10.1 2.312 .022 .47
 Hypomanic activation (RC9) 45.9 8.8 53.1 11.6 3.652 < .001 .70
MMPI-2 Clinical Scales
 Hypochondriasis (CS1) 77.3 10.2 75.5 12.6 − 0.804 .423 − .16
 Depression (CS2) 79.5 12.8 76.5 13.1 − 1.152 .252 − .23
 Hysteria (CS3) 80.4 14.8 76.8 15.7 − 1.181 .240 − .24
 Psychopathic deviate (CS4) 63.1 12.4 64.9 11.1 0.726 .469 .15
 Paranoia (CS6) 62.5 12.4 63.4 11.7 0.362 .718 .07
 Psychasthenia (CS7) 69.9 10.9 72.2 11.4 1.036 .302 .21
 Schizophrenia (CS8) 68.2 11.8 72.7 10.9 1.931 .056 .40
 Mania (CS9) 51.1 8.6 55.4 9.6 2.410 .017 .48
MMPI-2-RF specific problems Scales
 Malaise (MLS) 76.8 7.6 79.0 7.6 1.447 .150 .29
 Gastrointestinal complaints (GIC) 66.4 16.5 64.4 16.3 − 0.616 .539 − .13
 Head pain complaints (HPC) 65.5 10.3 64.5 9.1 − 0.502 .617 − .11
 Neurological complaints (NUC) 71.0 12.9 71.3 12.6 0.138 .890 .03
 Cognitive complaints (COG) 63.6 13.0 70.9 12.2 2.820 .006 .58
 Suicidal/death ideation (SUI) 56.4 17.4 56.9 16.3 0.149 .882 .03
 Helplessness/hopelessness (HLP) 52.6 11.3 57.5 14.7 1.956 .053 .38
 Self-doubt (SFD) 60.5 11.8 61.1 11.8 0.248 .805 .05
 Inefficacy (NFC) 55.4 11.2 58.2 10.1 1.252 .213 .26
 Stress/worry (STW) 58.2 10.0 60.7 11.9 1.183 .239 .23
 Anxiety (AXY) 58.7 14.2 64.8 17.4 1.971 .051 .38
 Anger proneness (ANP) 55.2 11.7 59.3 13.2 1.660 .100 .33
 Behavior-restricting fears (BRF) 54.9 12.1 58.3 12.6 1.377 .171 .28
 Multiple specific fears (MSF) 51.6 10.4 49.6 7.0 − 1.045 .298 − .24
 Juvenile conduct problems (JCP) 49.0 10.6 56.4 12.2 3.307 .001 .65
 Substance abuse (SUB) 47.8 8.0 56.9 12.6 4.782 < .001 .89
 Aggression (AGG) 48.4 8.5 54.8 12.9 3.188 .002 .60
 Activation (ACT) 49.0 9.8 50.9 10.9 0.936 .351 .19
 Family problems (FML) 53.5 12.1 55.7 12.0 0.873 .384 .18
 Interpersonal passivity (IPP) 50.5 9.3 52.3 11.6 0.871 .385 .17
 Social avoidance (SAV) 52.9 11.1 56.3 12.2 1.434 .154 .28
 Shyness (SHY) 51.8 10.9 55.6 11.7 1.692 .093 .34
 Disaffiliativeness (DSF) 53.4 12.7 60.2 17.2 2.391 .018 .46
distress. Several aspects of these findings warrant further 
discussion.
As just noted, mean comparisons of the RC and Clinical 
Scales tended to demonstrate much higher scores across the 
Clinical Scales. Moreover, the pattern of mean RC Scale 
scores appeared more consistent with the types of psychopa-
thology present in the sample. For example, approximately 
half of the sample had a comorbid major depressive disorder, 
which is consistent with the observed mean subthreshold 
elevations of approximately 62T on RCd (demoralization) 
and RC2 (low positive emotions). One would expect over-
all sample mean scores of 65T or higher only if the entire 
sample had major depressive disorder, which is not the case. 
Along the same lines, the observed mean elevation on RC1 
(somatic complaints) is to be expected among a sample of 
patients with chronic low back pain. In contrast, the Clinical 
Scales demonstrated a substantially higher mean score on its 
measure of depression (CS2); indeed, it was consistent with 
the 99th percentile in the general population. Moreover, the 
MMPI-2 Clinical Scales evidenced subthreshold to thresh-
old mean elevations on scales that did not reflect psychopa-
thology commonly found in this population (Psychopathic 
Deviate, Paranoia, and Schizophrenia). Taken together and 
in line with past research (McCord & Drerup, 2011), the 
MMPI-2-RF RC Scales appeared to evidence more interpre-
tive utility and particularly discriminant validity than did the 
MMPI-2 Clinical Scales in this setting.
Correlation comparisons across the MMPI-2-RF and 
MMPI-2 Scales more directly demonstrated the limita-
tions of the Clinical Scales. Whereas 7 of the 9 RC Scales 
(and several other MMPI-2-RF Scales) were significantly, 
meaningfully associated with the outcome variable, only 
one MMPI-2 Clinical Scale (Schizophrenia) demonstrated 
a significant association. The latter finding is consistent 
with most past research indicating that MMPI/MMPI-2 
Scale scores are not associated with outcomes in this setting 
(McGill, Lawlis, Selby, Mooney, & McCoy, 1983; Moore, 
Armentrout, Parker, & Kivlahan, 1986). However, notwith-
standing the limitations of its predecessors, the newest ver-
sion of the MMPI—the MMPI-2-RF—was meaningfully 
associated with outcomes in this study, likely owing to its 
improved psychometrics and convergence with modern 
models of psychopathology (Sellbom, Ben-Porath, & Bagby, 
2008).
Findings from mean comparisons of recovered and not 
recovered groups using a clinically significant change frame-
work generally converged with the correlational results. 
However, these findings have more direct clinical implica-
tions, as robust correlation coefficients do not necessarily 
translate to actual treatment gains or losses as a result of 
higher scores on a Scale. Moreover, the mean comparisons 
across recovered and not recovered groups enable practi-
tioners to identify which scores on a scale are most likely 
to be associated with a problematic outcome. Accordingly, 
the results indicated that practitioners should interpret 
the MMPI-2-RF with some flexibility rather than strictly 
adhere to interpretations of 65T or higher (for the purposes 
of identifying individuals at risk for poor emotional distress 
outcomes). For example, BXD demonstrated a large effect 
size (Cohen’s d = 1.02) in differentiating recovered and not 
recovered groups, with a mean score of 57T in the nonre-
covered group.
Treatment Implications
The findings of this study can be used to assist with inter-
pretation of the MMPI-2-RF in this setting, such that indi-
viduals with marked scores on scales associated with poor 
outcome can be provided targeted interventions to increase 
their chances of success. In order to inform treatment, a 
brief description of how scales with the most robust findings 
can impede treatment are described next, using the test’s 
Consistent with interpretive guidelines, Clinical Scales are K-corrected (Graham, 2012)
Italicized findings attained a statistically significant and clinically meaningful effect size (d ≥ .40)
MMPI-2-RF Minnesota Multiphasic Personality Inventory-2-Restructured Form, M mean, SD standard 
deviation, d Cohen’s d
Table 5  (continued) Scale name (abbreviation) Recovered 
(n = 91)
Not 
recovered 
(n = 33)
Statistical comparisons
M SD M SD t Sig. d
MMPI-2-RF personality-psychopathology-5 Scales
 Aggressiveness-revised (AGGR-r) 48.1 9.5 49.8 11.9 0.833 .406 .16
 Psychoticism-revised (PSYC-r) 53.3 10.2 57.6 8.7 2.147 .034 .45
 Disconstraint-revised (DISC-r) 45.4 7.4 56.1 11.7 6.014 < .001 1.12
 Negative emotionality/neuroticism-revised (NEGE-r) 59.9 11.8 64.1 11.9 1.734 .085 .35
 Introversion/low positive emotionality-revised (INTR-r) 58.0 12.9 57.6 13.1 − 0.154 .878 − .03
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interpretive manual as a guide (Ben-Porath & Tellegen, 
2008/2011).
Although individuals presenting with higher scores on 
the Emotional/internalizing scales (Emotional/internaliz-
ing dysfunction, dysfunctional negative emotions, helpless-
ness/hopelessness, stress/worry, and negative emotionality/
neuroticism-revised) might be initially motivated to engage 
in treatment due to their distress, they may disengage after 
their distress levels begin to subside. Scores on scales that 
assess negatively emotionality and its facets had the strong-
est associations with poorer emotional distress functioning 
post-treatment, indicating the importance of targeting these 
constructs in treatment planning. These findings converge 
with those of Marek, Block, and Ben-Porath (2014), who 
found that MMPI-2-RF markers of emotional distress, 
depression, and negative emotionality were associated with 
pain disability outcomes after spinal cord surgery.
Individuals with high scores on the Behavioral/exter-
nalizing dysfunction, hypomanic activation, and discon-
straint scales are likely to be noncompliant with treatment 
efforts due to excessive activation, antisocial orientation, or 
impulsivity. Unusual thoughts and cognitions, as evidenced 
by moderately elevated scores on scales such as Aberrant 
Experiences and psychoticism-revised, may interfere with 
treatment as well. Individuals with greater cynical and dis-
affiliative attitudes may have difficulty forming a therapeu-
tic relationship, and they may have less access to socially 
supportive others, which may account for the associations 
between RC3 and DSF with poor outcomes. The RC3 find-
ings are consistent with past research showing high scores 
on this scale can lead poor treatment engagement among 
national guard soldiers (Arbisi, Polusny, Erbes, Thuras, & 
Reddy, 2011). Finally, patients with higher scores on cogni-
tive complaints are likely to have a low tolerance for frustra-
tion, which could impede the benefits of participating in an 
intensive chronic pain treatment program.
Although not a focus of the current study, it is worth men-
tioning that the MMPI-2-RF Validity Scales can also aid in 
treatment efforts by assessing a patient’s response style. In 
the current study, approximately 13% of patients from the 
initial sample evidenced an invalid response style on the 
MMPI-2-RF. That is, these individuals demonstrated incon-
sistent responding or overreporting of psychopathology or 
somatic/cognitive complaints. Past research in other settings 
has demonstrated that MMPI-2-RF identified overreporting 
is likely to generalize to other aspects of the assessment 
(Forbey, Lee, Ben-Porath, Arbisi, & Gartland, 2013). Thus, 
in situations where an individual produces an invalid proto-
col, practitioners should be aware of the limitations of con-
currently obtained patient data. Invalid protocols may also 
have implications for treatment, as demonstrated by studies 
in mental health settings (Anestis, Finn, Gottfried, Arbisi, 
& Joiner, 2014). However, future research on the utility of 
the MMPI-2-RF Validity Scales for this purpose in chronic 
pain treatment is needed.
Limitations and Conclusion
Limitations of the current study provide direction for future 
research. The sample was entirely composed of low back 
pain patients. Although low back pain is the most common 
complaint of individuals in this setting, it would be use-
ful to see whether these findings generalize to other diag-
noses, such as fibromyalgia, chronic fatigue syndrome, 
migraine headaches, multiple sclerosis, and other neuro-
logical disorders. Moreover, replication of these results in 
other types of chronic pain treatment settings is necessary, 
as the patients in the current study participated in a struc-
tured interdisciplinary pain treatment program that was very 
intensive. Although such a program is recommended, it does 
not represent the treatment received by most pain patients. 
Additionally, given the intensive nature of the program, the 
severity of chronic pain and comorbid diagnoses such as 
prescription opioid abuse may be greater than what is typi-
cally observed in outpatient settings. The results of the study 
were analyzed in the context of exploration (Reichenbach, 
1938), given the limited available research on the MMPI-
2-RF and chronic pain treatment outcomes. Consequently,
replication is needed. Moreover, the current study utilized
only one outcome measure—future research with multiple
and varied methods of outcomes assessment are indicated.
Along the same lines, some patient characteristics were not
assessed but could be relevant to the generalizability of the
study (e.g., treatment satisfaction). Finally, investigating
associations of MMPI-2-RF scores with other indicators of
outcome would be beneficial and may provide additional
insight into the utility of the instrument in assessments of
patients with chronic low back pain. For example, the Exter-
nalizing Scales may be useful in the prediction of treatment
nonadherence.
These limitations notwithstanding, the current study 
is the first to investigate the utility of the MMPI-2-RF in 
the prediction of treatment outcomes among chronic pain 
patients undergoing conservative treatments. Overall, the 
results of this study provide preliminary support for the use 
of the MMPI-2-RF among patients with chronic low back 
pain and should ease long-standing concerns that an MMPI 
instrument is not useful in this setting.
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